The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase I (Q47096384)
Jump to navigation
Jump to search
scientific article published on 28 December 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase I |
scientific article published on 28 December 2017 |
Statements
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI (English)
Andreas Wunsch
Thorsten O Goetze
Nils Homann
Hauke Lang
Karel Caca
Harald Schmalenberg
Salah-Eddin Al-Batran
Daniel W Mueller
Arndt Vogel
Michael Winkler
Sylvie Lorenzen
Alexander Novotny
Thomas Jungbluth
Steffen Retter
Eva Horndasch
Julia Gumpp
Claus Bolling
Karl-Hermann Fuchs
Wolfgang Blau
Winfried Padberg
Michael Pohl
Patrick Michl
Frank Mannes
Matthias Schwarzbach
Michael Hohaus
Christian Scholz
Christoph Benckert
Jorge Riera Knorrenschild
Veit Kanngießer
Thomas Zander
Hakan Alakus
Ralf-Dieter Hofheinz
Claus Roedel
Manish A Shah
Mitsuru Sasako
Dietmar Lorenz
Jakob Izbicki
1 reference
1 reference
1 reference
Identifiers
1 reference